Eckert & Ziegler SE (ETR:EUZ)

Market Cap	1.23B
Revenue (ttm)	295.85M
Net Income (ttm)	33.28M
Shares Out	20.85M
EPS (ttm)	1.59
PE Ratio	30.79
Forward PE	24.60
Dividend	0.05 (0.09%)
Ex-Dividend Date	Jun 19, 2025

Volume	46,658
Average Volume	47,627
Open	56.40
Previous Close	56.10
Day's Range	56.10 - 58.80
52-Week Range	36.30 - 62.05
Beta	1.50
RSI	62.09
Earnings Date	Mar 27, 2025

About Eckert & Ziegler SE

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynt...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2024
• Employees: 1,085
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: EUZ

Financial Performance

In 2024, Eckert & Ziegler SE's revenue was 295.85 million, an increase of 20.22% compared to the previous year's 246.09 million. Earnings were 33.28 million, an increase of 26.52%.